Cargando…

Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies

BACKGROUND: Many biological factors of 2-[(18) F]fluoro-2-deoxy-d-glucose ((18) F-FDG) in blood can affect (18) F-FDG uptake in tumors. In this study, longitudinal (18) F-FDG positron emission tomography (PET) studies were performed on tumor-bearing mice to investigate the effect of blood glucose le...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Wei, Ye, Hu, Iwamoto, Keisuke S, Wong, Koon-Pong, Wilks, Moses Quinn, Stout, David, McBride, William, Huang, Sung-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718724/
https://www.ncbi.nlm.nih.gov/pubmed/23841937
http://dx.doi.org/10.1186/2191-219X-3-51
_version_ 1782277811320389632
author Sha, Wei
Ye, Hu
Iwamoto, Keisuke S
Wong, Koon-Pong
Wilks, Moses Quinn
Stout, David
McBride, William
Huang, Sung-Cheng
author_facet Sha, Wei
Ye, Hu
Iwamoto, Keisuke S
Wong, Koon-Pong
Wilks, Moses Quinn
Stout, David
McBride, William
Huang, Sung-Cheng
author_sort Sha, Wei
collection PubMed
description BACKGROUND: Many biological factors of 2-[(18) F]fluoro-2-deoxy-d-glucose ((18) F-FDG) in blood can affect (18) F-FDG uptake in tumors. In this study, longitudinal (18) F-FDG positron emission tomography (PET) studies were performed on tumor-bearing mice to investigate the effect of blood glucose level and tumor size on (18) F-FDG uptake in tumors. METHODS: Six- to eight-week-old severe combined immunodeficiency mice were implanted with glioblastoma U87 (n = 8) or adenocarcinoma MDA-MB-231 (MDA) (n = 11) in the shoulder. When the tumor diameter was approximately 2.5 mm, a 60-min dynamic (18) F-FDG PET scan was performed weekly until the tumor diameter reached 10 mm. Regions of interests were defined in major organs and tumor. A plasma curve was derived based on a modeling method that utilizes the early heart time-activity curve and a late-time blood sample. The (18) F-FDG uptake constant K(i) was calculated using Patlak analysis on the tumors without an apparent necrotic center shown in the PET images. For each tumor type, the measured K(i) was corrected for partial volume (PV), and multivariate regression analysis was performed to examine the effects of blood glucose level ([Glc]) and tumor growth. Corrected Akaike's information criterion was used to determine the best model. RESULTS: The regression model that best fit the PV-corrected K(i) for U87 data was K(i)/RC = (1/[Glc]) × (0.27 ± 0.027) mL/min/mL (where [Glc] is in mmol/L), and for MDA, it was K(i)/RC = (0.04 ± 0.005) mL/min/mL, where K(i)/RC denotes the PV-corrected K(i) using an individual recovery coefficient (RC). The results indicated that (18) F-FDG K(i)/RC for U87 was inversely related to [Glc], while [Glc] had no effect on (18) F-FDG K(i)/RC of MDA. After the effects of PV and [Glc] were accounted for, the data did not support any increase of (18) F-FDG K(i) as the tumor (of either type) grew larger in size. CONCLUSIONS: The effect of [Glc] on the tumor (18) F-FDG K(i) was tumor-dependent. PV- and [Glc]-corrected (18) F-FDG K(i) did not show significant increase as the tumor of either type grew in size.
format Online
Article
Text
id pubmed-3718724
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-37187242013-07-23 Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies Sha, Wei Ye, Hu Iwamoto, Keisuke S Wong, Koon-Pong Wilks, Moses Quinn Stout, David McBride, William Huang, Sung-Cheng EJNMMI Res Original Research BACKGROUND: Many biological factors of 2-[(18) F]fluoro-2-deoxy-d-glucose ((18) F-FDG) in blood can affect (18) F-FDG uptake in tumors. In this study, longitudinal (18) F-FDG positron emission tomography (PET) studies were performed on tumor-bearing mice to investigate the effect of blood glucose level and tumor size on (18) F-FDG uptake in tumors. METHODS: Six- to eight-week-old severe combined immunodeficiency mice were implanted with glioblastoma U87 (n = 8) or adenocarcinoma MDA-MB-231 (MDA) (n = 11) in the shoulder. When the tumor diameter was approximately 2.5 mm, a 60-min dynamic (18) F-FDG PET scan was performed weekly until the tumor diameter reached 10 mm. Regions of interests were defined in major organs and tumor. A plasma curve was derived based on a modeling method that utilizes the early heart time-activity curve and a late-time blood sample. The (18) F-FDG uptake constant K(i) was calculated using Patlak analysis on the tumors without an apparent necrotic center shown in the PET images. For each tumor type, the measured K(i) was corrected for partial volume (PV), and multivariate regression analysis was performed to examine the effects of blood glucose level ([Glc]) and tumor growth. Corrected Akaike's information criterion was used to determine the best model. RESULTS: The regression model that best fit the PV-corrected K(i) for U87 data was K(i)/RC = (1/[Glc]) × (0.27 ± 0.027) mL/min/mL (where [Glc] is in mmol/L), and for MDA, it was K(i)/RC = (0.04 ± 0.005) mL/min/mL, where K(i)/RC denotes the PV-corrected K(i) using an individual recovery coefficient (RC). The results indicated that (18) F-FDG K(i)/RC for U87 was inversely related to [Glc], while [Glc] had no effect on (18) F-FDG K(i)/RC of MDA. After the effects of PV and [Glc] were accounted for, the data did not support any increase of (18) F-FDG K(i) as the tumor (of either type) grew larger in size. CONCLUSIONS: The effect of [Glc] on the tumor (18) F-FDG K(i) was tumor-dependent. PV- and [Glc]-corrected (18) F-FDG K(i) did not show significant increase as the tumor of either type grew in size. Springer 2013-07-10 /pmc/articles/PMC3718724/ /pubmed/23841937 http://dx.doi.org/10.1186/2191-219X-3-51 Text en Copyright ©2013 Sha et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Sha, Wei
Ye, Hu
Iwamoto, Keisuke S
Wong, Koon-Pong
Wilks, Moses Quinn
Stout, David
McBride, William
Huang, Sung-Cheng
Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
title Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
title_full Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
title_fullStr Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
title_full_unstemmed Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
title_short Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
title_sort factors affecting tumor (18) f-fdg uptake in longitudinal mouse pet studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718724/
https://www.ncbi.nlm.nih.gov/pubmed/23841937
http://dx.doi.org/10.1186/2191-219X-3-51
work_keys_str_mv AT shawei factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT yehu factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT iwamotokeisukes factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT wongkoonpong factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT wilksmosesquinn factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT stoutdavid factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT mcbridewilliam factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies
AT huangsungcheng factorsaffectingtumor18ffdguptakeinlongitudinalmousepetstudies